Form 8-K - Current report:
SEC Accession No. 0001493152-25-003985
Filing Date
2025-01-28
Accepted
2025-01-28 16:10:34
Documents
15
Period of Report
2025-01-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43401
2 ex10-1.htm EX-10.1 89341
3 ex10-1_001.jpg GRAPHIC 12769
  Complete submission text file 0001493152-25-003985.txt   335717

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE shph-20250123.xsd EX-101.SCH 3030
5 XBRL LABEL FILE shph-20250123_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE shph-20250123_pre.xml EX-101.PRE 24175
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 25564241
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)